97048 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
Method of detecting β3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor
#302Purification and characterization of soluble human HLA proteins
#303Novel assays utilizing nicotinic acetylcholine receptor subunits
#304Transgenic mice containing glutamate receptor (GRIK5) gene disruptions
#305Amino acid sequences capable of facilitating penetration across a biological barrier
#306Receptor
#307Endogenous and non-endogenous versions of human G protein-coupled receptors
#308Endogenous and non-endogenous versions of human G protein-coupled receptors
#309Novel receptor
#310Chimeric gaba receptor
#311GABA B1A receptor disruptions, compositions and methods relating thereto
#312Neuropeptide Y receptor Y5 and nucleic acid sequences
#313Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
#314Serotonin receptor
#315Receptor assay
#316GABAreceptor epsilon subunits
#317Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3
#318Transgenic mice containing chordin gene disruptions
#319Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof
#320Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
#321Molecular linkers suitable for crystallization and structural analysis of molecules of interest, method of using same, and methods of purifying g protein-coupled receptors
#322Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit
#323Nicotinic acetylcholine receptor
#324Assay methods for identifying RE2-like antagonists, methods of use, and non-human transgenic animals
#325Methods of identifying modulators of NMUR2-mediated activity
#326Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity
#327Trace amine receptor 1 of the African green monkey
#328Splice variant cannabinoid receptor (cb1b)
#329Reducing NgR-p75 mediated inhibition of axon regeneration
#330Mutation associated with epilepsy
#331Transgenic mice containing GPCR-like gene disruptions
#332Genetic predictor of efficacy of anti-asthmatic agents for improving pulmonary function
#333Glutamate receptors and utilization thereof
#334Epitope testing using soluble HLA
#335Immunomodulation and effect on cell processes relating to serotonin family receptors
#336Method for identifying modulators of human orexin-2 receptor
#337Neuroprotective therapeutics preventing ERK/MAPK activation through the NMDA receptor
#338Novel human GABA receptor proteins and polynucleotides encoding the same
#339Chimp trace amine associated receptors and polypeptides
#340Nematode neuromuscular junction GABA receptors and methods related thereto
#341Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
#342Intralesional treatment of psoriasis
#343DNA encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and a recombinant cell line expressing a functional human alpha7 subunit of neuronal nicotinic acetylcholine receptor
#344Method of identifying transmembrane protein-interacting compounds
#345Flea octopamine receptor nucleic acid molecules, proteins and uses thereof
#346Modified IGF1 polypeptides with increased stability and potency
#347Glutamate receptor and utilization thereof
#348DNA molecules encoding ligand-gated ion channels from
#349DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
#350Chimeric nicotinic receptor subunits
#351Novel G protein-coupled receptors
#352Human 5-ht7 receptor promoter sequence
#353Ten-M3 polypeptides and polynucleotides and their methods of use
#354Animal model, cells, and treatment for malignant melanoma
#355Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
#356Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
#357Human neuropeptide Y-like G protein-coupled receptor
#358Chimeric neuropeptide Y receptors
#359Amino acid sequences capable of facilitating penetration across a biological barrier
#360Expression of G protein coupled receptors in yeast
#361Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity
#362Modulation of brain pathways and function
#363Cytoplasmic inhibition of gene expression
#364Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ch receptor antibodies from myasthenic patients
#365VPAC1 selective antagonists and their pharmacological methods of use
#366Novel spliced 5-HT1A receptors and methods, kits, and uses relating thereto
#367Chimeric metabotropic glutamate receptors and uses thereof
#368G protein-coupled receptor-like receptors and modulators thereof
#369Transgenic GPCR expressing animals
#370Novel human proteins and polynucleotides encoding them
#371Orphanin FQ receptor
#372Assay employing G protein-coupled receptor expressed in dorsal root ganglia
#373Nr3b nmda receptor subunit compositions and related methods
#374Process of high purity albumin production
#375GABA B receptors
#376Compositions capable of facilitating penetration across a biological barrier
#377Novel GABAB receptor DNA sequences
#378Human 5-HT3-C protein
#379Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof
#380Anticoagulant fusion protein anchored to cell membrane
#381Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
#382Novel human neurexin-like proteins and polynucleotides encoding the same
#383Method of modulating cell survival and reagents useful for same
#384DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
#385Modified tachykinin receptors
#386Regulation of human serotonin-like g protein-coupled receptor
#387Amplification and overexpression of oncogenes
#388G-protein coupled receptor
#389Cation conducting GABA receptors and their use
#390Hypocretin receptor in regulation of sleep and treatment of sleep disorders
#391Identification of potential immunodominant acetylcholine receptor alpha subunit
#392Knock-in-mouse
#393Pain signaling molecules
#394Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
#395Mutation in the beta2 nicotinic acetycholine receptor subunit associated with nocturnal frontal lobe epilepsy
#396Chimeric neuropeptide Y receptors
#397Methods of attaching soluble HLA to solid supports
#398Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions
#399Glucocorticoid-induced receptor and methods of use
#400Comparative ligand mapping from MHC class 1 positive cells
#401Glutamic acid receptor and utilization thereof
#402Method of screening for compounds that modulate activity of a regulatory sequence of the β-2 subunit of a neuronal nicotinic acetylcholine receptor
#403High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable composition
#404A4B2 nicotinic acetylcholine receptors with reduced or increased nicotine sensitivity and transgenic mouse model for the same